ValorQ4, 24Q1, 25Q2, 25Total de pasivos39.55 M39.32 M39.81 MCapital total-865 K-5.65 M-9.21 MTotal de pasivos y patrimonio neto38.68 M33.67 M30.6 MDeuda total27.29 M33.57 M33.93 MDeuda neta5.38 M17.18 M20.28 M
Pluri Inc
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.